These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 4780351

  • 1. [The pathobiology of TRIC agents].
    Jawetz E.
    Rev Int Trach; 1973; 50(3):27-38. PubMed ID: 4780351
    [No Abstract] [Full Text] [Related]

  • 2. Virulence and host specificity of TRIC agents.
    Moore JE, Griffiths MS, Pearce JH.
    J Gen Microbiol; 1969 Dec; 59(3):iv-v. PubMed ID: 4984857
    [No Abstract] [Full Text] [Related]

  • 3. The agent of trachoma. Recent studies of the biology, biochemistry and immunology of a prokaryotic obligate parasite of eukaryocytes.
    Becker Y.
    Monogr Virol; 1974 Dec; 7():1-99. PubMed ID: 4364815
    [No Abstract] [Full Text] [Related]

  • 4. [Characteristics and unknowns of TRIC agents (trachoma--inclusion conjunctivitis)].
    Nabli B.
    Rev Int Trach Pathol Ocul Trop Subtrop; 1980 Dec; 57(4):71-5. PubMed ID: 7280402
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Folliculosis, TRIC (trachoma--inclusion conjunctivitis) and the carrier state.
    Scott JG, Cuthbertson EM, Ryan J.
    S Afr J Med Sci; 1972 Jul; 37(1):23-5. PubMed ID: 4656286
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Three new immunologic types of trachoma-inclusion conjunctivitis organisms.
    Wang SP, Grayston JT, Gale JL.
    J Immunol; 1973 Mar; 110(3):873-9. PubMed ID: 4631875
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Latency in human infections with TRIC agents.
    Hanna L, Dawson CR, Briones O, Thygeson P, Jawetz E.
    J Immunol; 1968 Jul; 101(1):43-50. PubMed ID: 4173937
    [No Abstract] [Full Text] [Related]

  • 13. Advances in the microbiology of trachoma and related diseases.
    Jones BR.
    Trans Ophthalmol Soc N Z; 1973 Jul; 25():187-91. PubMed ID: 4586696
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys.
    Wang SP, Grayston JT.
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1133-45. PubMed ID: 4960878
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Isolation and identification of trachoma and inclusion conjunctivitis agents in Melbourne, 1966 to 1972.
    Graham DM, Pinkard KJ, Layton JE, Greer CH, Davis JA.
    Med J Aust; 1973 Jun 02; 1(22):1095-9. PubMed ID: 4351871
    [No Abstract] [Full Text] [Related]

  • 18. Effect of polycations, polyanions and neuraminidase on the infectivity of trachoma-inclusin conjunctivitis and lymphogranuloma venereum organisms HeLa cells: sialic acid residues as possible receptors for trachoma-inclusion conjunction.
    Kuo CC, Wang SP, Grayston JT.
    Infect Immun; 1973 Jul 02; 8(1):74-9. PubMed ID: 4718924
    [Abstract] [Full Text] [Related]

  • 19. A study of urethritis in males with particular reference to mycoplasma and TRIC-agent.
    Mukhija RD, Gupta U, Bhujwala RA, Mahajan VM, Bhutani LK, Kandhari KC.
    Indian J Med Res; 1973 Dec 02; 61(12):1766-70. PubMed ID: 4206938
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.